UNSPSC 51282911: Danofloxacin

This classification denotes a quinolone antibiotic with the molecular formula C19H20FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 24CU1YS91D chemically known as 1-cyclopropyl-6-fluoro-1,4-dihydro-7-((1s,4s)-5-methyl-2,5-diazabicyclo(2.2.1)hept-2-yl)-4-oxo-3-quinolinecarboxylic acid but generally known as danofloxacin, which bears US NIH Compound Identifier 71335. European Medicines Agency schedules Danofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06901MIG.

UNSPSC 51282911 Danofloxacin, a Commodity code, nominally designates a specific veterinary antibiotic; however, recent state and local activity under this code does not reflect procurement of danofloxacin itself. Instead, the few opportunities tagged to this code show state and local health agencies sourcing related pharmaceutical products and health-support items through piggyback contracts and competitive bids. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets supplied through a 12-month initial term with two renewal options, totaling $2,999,999.11 over the contract life. The scope of work under this code reflects pharmaceutical supply and distribution to state public-health agencies, typically through established cooperative frameworks or open competitive bidding.

State and local solicitations under this code originate from state health departments and county health authorities. The geographic spread of recent activity is limited; Illinois and Florida are the two states with posted opportunities in the source. Seminole County, Florida solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through an IFB posted June 30, 2026, with a response deadline of July 26, 2023 (note: the response date in the source appears inconsistent with the post date and likely reflects a data-entry error in the underlying record). The Illinois Department of Public Health opportunity represents a completed award rather than an open solicitation. Both opportunities required vendors to meet drug-free workplace certification, E-Verify compliance, and standard insurance and bonding requirements. The code shows minimal recent activity; firms evaluating this category should note the mismatch between the nominal commodity scope (danofloxacin) and what is actually being procured (broader pharmaceutical and health-support items through cooperative and direct-buy channels).